Clinical Trials Directory

Trials / Unknown

UnknownNCT05375331

Clinical and Genetic Markers of Bone Metabolism in Children Under One Year

Clinical and Genetic Markers of Bone Metabolism in Children Under One Year of Age in the Kazakh Population

Status
Unknown
Phase
Study type
Observational
Enrollment
245 (estimated)
Sponsor
West Kazakhstan Medical University · Academic / Other
Sex
All
Age
1 Day – 1 Year
Healthy volunteers

Summary

The study of children under one year of age for molecular genetic testing-VDR (rs1544410, rs2228570), RANKL (rs9594738, rs9594759) with the study of the frequency distribution of alleles and genotypes by polymorphisms, analysis of the relationship of molecular genetic markers with indicators of bone metabolism.

Detailed description

Children under the age of one year of Kazakh nationality born in Aktobe will be examined. Each child included in the study will have an individual registration card, where information about the health status of the child and the health status of the mother during pregnancy will be filled in. A biochemical analysis will be determined for the level of calcium, phosphorus, calcitonin, parathyroid hormone, osteocalcin, vitamin D in blood serum and deoxypyridinoline in urine. Blood will be taken to determine the genetic polymorphism of VDR (rs1544410, rs2228570), RANKL (rs9594738, rs9594759). The state of bone tissue remodeling (osteocalcin, vitamin D, Ca, P, calcitonin, deoxypyridinoline) will be revealed The frequencies of allelic variants of the VDR (rs1544410, rs2228570), RANKL (rs9594738, rs9594759) genes in children under the age of one year in the population of Kazakhstan were determined.

Conditions

Timeline

Start date
2020-12-31
Primary completion
2024-03-01
Completion
2024-03-01
First posted
2022-05-16
Last updated
2023-04-25

Locations

1 site across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT05375331. Inclusion in this directory is not an endorsement.